Objectives: To assess the effect of topically-applied nitroglycerin (NTG) ointment (2%) on preoperative venous access site great saphenous vein (GSV) diameter in patients undergoing endovenous laser treatment (ELT). Methods: In this patient blinded randomized allocation consecutive enrolment study, (75) patients received either (a) treadmill ambulation only, (b) topically-applied NTG ointment only or (c) topically-applied NTG ointment and treadmill ambulation. Vein diameters were measured before therapeutic intervention and then repeated after approximately 30 min. Presence of venospasm and the number of ultrasound-guided venous access attempts during each ELT procedure were assessed during the study. Results: The mean pre-treatment vein diameter was 2.6 mm (range 0.9-4.9 mm). The post-treatment percentage change in vein diameter for Group A (treadmill ambulation only) was þ 2.7 % (P-value ¼ 0.403), whereas Group B (NTG only) and Group C (NTG and treadmill ambulation) demonstrated significant venodilatation of þ 69.0 % (P-value ,0.001) and þ 51.7% (P-value ,0.001), respectively. Statistical analysis of variances and multivariate linear regression model revealed topically-applied NTG ointment and advanced stages of CVI were each significant predictors for venodilatation percentage change (P-values ,0.001 and ¼ 0.028, respectively). Conclusions: Pretreatment with topically-applied NTG ointment (2%) produced a statistically significant, as well as subjective clinically significant, venodilatation change in the venous access site diameter of patients undergoing ELT of the GSV in this study.
Disclosure information was provided at the time of abstract submission. Objectives: To review our experience and outcomes of 208 patients who underwent office-based endovenous ablation using either radiofrequency or the 1320 nm laser. Methods: Details of their presenting complaints, physical examination, duplex exam, treatment and outcomes at 1 week, 3 months, 6 months and 1 year were noted. Results: The mean age was 52.9 (range 21 -85 years) and 84% were women. The clinical, aetiological, anatomical and pathological elements (CEAP) classification ranged between 2 -6 (mean ¼ 2.9). One hundred and fifteen were C3, 58 were C2 and 27 were C4. One hundred and thirteen patients underwent endovenous saphenous ablation using the 1320 nm laser and 70 patients underwent the radiofrequency method. One hundred and five patients also underwent concomitant microphlebectomy (43) or sclerotherapy (62) at the same setting. Postoperative complications included: two patients reported back to the office the same day for bleeding from the microphlebectomy sites; five patients developed painful haematomas along the great saphenous vein at aneurismal sites; three patients developed asymptomatic endovenous heat-induced thrombus; and three patients had recurrence of either reflux or varicose veins within a year of endovenous ablation. They all occurred in the thigh and occurred early in our experience.
Conclusions:
The utilization of the radiofrequency or the 1320 nm laser for the purpose of endovenous ablation of incompetent saphenous veins is a safe procedure with the proper training. It can be done with local anaesthesia in an office-based setting with low morbidity. Disclosure information was provided at the time of abstract submission.
Potential Objectives: It seems intuitive that extremities with varicose veins in patients with more severe chronic venous disease clinical, aetiological, anatomical and pathological elements (CEAP) clinical classifications C3 to C6) should have more valvular insufficiency than extremities with oedema, skin changes and/or ulcers (C3, C4, C5-C6), but without varicose veins. Data analysis to support this concept, however, seems needed. We investigated if varicose veins affected the prevalence of venous reflux in extremities with oedema, skin changes and/or ulcers.
Methods: Presence of reflux in the great saphenous, anterior accessory saphenous and superficial tributaries of the thigh was investigated in 120 C3 -C6 extremities. Varices were noted in 57 (48%) of these extremities. Reflux prevalence in C3 -C6 plus C2 vs. C3-C6 extremities without varices was compared by Chi-square.
Results: Prevalence of reflux in the C3 -C6 plus C2 group, 68% (39/57), was significantly higher than in the C3 -C6 extremities without varicosities, 35% (22/63) (P , 0.001). Subgroup analysis revealed that prevalence of reflux was also higher in extremities with 'end-of-the day', intermittent, positional or occupational oedema (C3 mild) plus varicose veins, 76% (13/17), than in extremities with mild oedema, but no varicose veins, 34% (10/29) (P ¼ 0.006).
Conclusions: Varicosities were a factor for higher prevalence of superficial venous valvular insufficiency in extremities with oedema, skin changes and/or ulcers. Disclosure information was provided at the time of abstract submission. Objectives: The present study examines the treatment of 90 patient limbs with saphenofemoral junction incompetence with simultaneous treatment of associated truncal varicosities by ambulatory phlebectomy. Methods: Four-year follow-up data for recurrence rate and complication profile was ascertained for 90 patients (mean age 40 years) with saphenofemoral junction reflux associated with greater saphenous vein incompetence (4-12 mm -mean 7.8 mm) and enlargement of branch varicosities as documented by Duplex ultrasound, which were treated with a combined approach of endovascular laser obliteration of the greater saphenous vein (810 nm, Diomed S30) followed by ambulatory phlebectomy of the remaining truncal varicosities. Follow-up by Duplex ultrasound to ensure closure was carried out at week 1 and months 1, 3, 6, 12, 24, 36 and 48.
Results: A total recurrence rate r ¼ 94 limbs of 4.3% was found in the patient cohort. All recurrences occurred within 12 months with the majority documented at month 6. Complications included ecchymoses, paresthesias and hyperpigmentation. Conclusions: Combination endovenous laser therapies with ambulatory phlebectomy is an effective treatment modality for superficial venous incompetence in the outpatient ambulatory setting. Low recurrence rates are noted with this approach. In the present patient series most recurrences were noted within 12 months of the aforementioned procedure. Disclosure information was provided at the time of abstract submission. Objectives: A patient's postoperative course following endovenous laser ablation (EVLA) of the great saphenous vein can be variable. The purpose of this study is to examine if a correlation exists between Joules/cm 2 and the incidence of postoperative phlebitis, eccymosis or pain. Methods: For each patient (n ¼ 108) undergoing EVLA (940 nm) of the great saphenous vein, the saphenous segment treated was measured in centimetres from the point of access to the saphenofemoral junction. Joules per centimetre square was calculated utilizing total joules delivered along the course of the measured segment. Each patient was seen in follow-up at one week and clinically assessed for phlebitis, pain and degree of eccymosis on a scale of zero to five.
Results: Phlebitis was not demonstrated in 87% (n ¼ 105) of the patients when an average of 66 J/cm 2 was delivered. Two patients reported severe symptoms and exhibited signs of phlebitis with an average of 82 J/cm 2 . The majority of the patients (60%) rated their pain zero to one with an average of 65 J/cm 2 . A small group of patients (4.6 %), who reported their postoperative pain a four received an average of 74 J/cm 2 . In a majority of the patients (86 %) eccymosis was clinically assessed at a zero to two with an average of 69 J/cm 2 .
